Equigerminal


: 1 déc. 2020


Recherche partenariat En recherche d'un consultant En recherche de financements
A propos

Equigerminal  is a Vet  biotech specialised in viral discovery, monitoring and control by using an One Health approach.

Emerging infectious diseases (EIDs) and climate change are the threats of the coming decades. . It’s is estimated that there are as 1,67 Million unknown viruses out there. The SARS-CoV-2 was one of this virus that emerged from animals and caused the current pandemics, but many others are harbouring and evolving in animals that need to be characterized, monitored and controled for the preparedness of the next ;

Our ativities are mainly the developemnt of innovative tools - diagnosis, antivirals and vaccines- to control emerging viral threats.

Our projects: 

1- Refinement of a R&D+I  platform to monitor emerging viral threats and enable rapid develpment of diagnostics, antivirals and vaccines

2-  Refinenment of diagnosis, antivirals and vaccines for two newly discovered virus and better understanding of the zoonotic potential of this newly uncovered ;

To date Equigerminal discovered two uncovered potential letal virus, the lentivirus New Equine Virus (NEV) in Equines  and the X-virus in Humans that are associated to fatal respiratory and neurologic disorders.

3- Refinement and monitoring of SARS-CoV-2 in animal ;

 

Mots clés et domaine d'activité:

 Vétérinaire
 Santé et bien-être des animaux
 Soins de santé
 Médicaments
 Biotechnologie

Idées proposées

Appels à projets suivis
Pas d'appels à projets suivis!